http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190018809-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate | 2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd38e52373606c691d80d85d8fafe52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d106dc929d5053f72cf27f8322814df4 |
| publicationDate | 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190018809-A |
| titleOfInvention | Anti-cancer composition including GKN1 protein |
| abstract | The present invention relates to a composition for the prophylaxis or treatment of gastric cancer, which comprises GKN1 protein (Exosomal Gastrokine-1 protein) as an active ingredient, wherein the GKN1 protein-containing exosome is secreted from cells expressing GKN1 protein, Is isolated from the culture supernatant of cells expressing the cancer cell, and is internalized as cancer cells by Clathrin to inhibit cell proliferation of cancer cells and induce apoptosis of cancer cells, thereby being useful for prevention or treatment of gastric cancer. |
| priorityDate | 2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 330.